Edwards Lifesciences quarterly revenue rises 10.5% to $1.72 billion
Edwards Lifesciences' revenue growth is slowing. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Nov 4, 2026.
100.82▲ +1.46%
Latest · 2026-11-06
Edwards Lifesciences' revenue growth is slowing. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Nov 4, 2026.
2026-11-06